Durant J

Publications (2)5.07 Total impact

• Source

  Available from: David Rey

  Article: Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

  FATKENHEUER G, DUVIVIER C, RIEGER A, DURANT J, REY D, SCHMIDT W, HILL A, van DELFT Y, MARKS S
  Journal of Antimicrobial Chemotherapy 01/2012; 67:685-690. · 5.07 Impact Factor
• Article: Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

  Fätkenheuer G, Duvivier C, Rieger A, Durant J, Rey D, Schmidt W, Hill A, van Delft Y, Marks S, on behalf of the SENSE Study Team
  J Antimicrob Chemother. 01/2011;